Aronne LJ et al., SURMOUNT-5 head-to-head, NEJM 2024 (NEJMoa2416394) : tirzepatide vs semaglutide, advantage tirzepatide of approximately 6 points
Then a lab analyzed BS-2025 and found it was an inert placebo and you know what the BS stand for
Questionable and unverifiable certifications and doctor endorsements While the Oyikey website throws around names and logos of regulatory agencies and certification bodies like the MHRA, British Pharmacopoeia (BP) and Good Manufacturing Practices (GMP), there is no way for the average consumer to fact-check if the patch is actually approved by these organizations
Going forward this provides a valuable yardstick for evaluating the benefits of GLP-1 drugs which have been used since 2005
Understanding Your Prescription Options Wegovy Illinois: As a once-weekly injectable, Wegovy is FDA-approved for chronic weight management
Before the lag time, 12% of the thyroid cancer group and 9.6% of the control group used GLP-1 receptor agonists, with more than 80% in both groups using liraglutide (Victoza, Novo Nordisk)
